Company Filing History:
Years Active: 2009-2011
Title: The Innovative Journey of Inventor Xinglong Jiang
Introduction
Xinglong Jiang, based in Hillsborough, NJ, is a noted inventor recognized for his contributions to pharmaceutical formulations and processes. With a total of two patents to his name, Jiang’s innovations focus on the development of novel compounds that contribute to medical advancements.
Latest Patents
Jiang's latest patents showcase his expertise in chemistry and pharmaceuticals. The first patent, titled "Salts and crystal modifications thereof," involves salts of 1-(2-Fluoro-phenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea. This invention outlines various crystalline forms, their production methods, and pharmaceutical preparations featuring these salts and crystalline forms.
In his second patent, "Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates," Jiang presents a method for producing intermediates that are essential for synthesizing antibacterial N-formyl hydroxylamine compounds, which act as peptide deformylase inhibitors. The process incorporates the use of αβ-lactam intermediates, and also claims certain optically pure intermediates.
Career Highlights
Xinglong Jiang is currently employed at Novartis AG, a global healthcare company renowned for its focus on innovative medicines. His work in this esteemed organization has enabled him to advance his research and development initiatives in the pharmaceutical sector.
Collaborations
At Novartis, Jiang collaborates with a talented team of professionals, including his coworkers Prasad Koteswara Kapa and Eric M Loeser. These collaborations enhance his research capabilities and contribute to the successful development of impactful medicinal inventions.
Conclusion
Xinglong Jiang's innovative spirit and dedication to pharmaceutical sciences exemplify the essence of modern invention. With two valuable patents to his name, he continues to push boundaries in the field, contributing to advancements that hold the potential to make significant impacts on healthcare.